CEN Biotech, Inc. (CENBF)
| Market Cap | 65.00 |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -3.10M |
| Shares Out | 65.26M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 184 |
| Average Volume | 2,423 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | n/a |
| Beta | -6.58 |
| RSI | 45.11 |
| Earnings Date | Aug 14, 2025 |
About CEN Biotech
CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. It intends to cultivate hemp for usage in industrial, medical, and food products; and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada. [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CEN Biotech Inc. Announces Planned Strategic Expansion of Business and Closing of Clear Com Media Inc. Acquisition
WINDSOR, ON / ACCESSWIRE / July 12, 2021 / CEN Biotech Inc. ('CEN' or the 'Company') (OTC PINK:CENBF), a global holding company focused on the manufacturing, production and development of LED lighting...
CEN Biotech Inc. Announces Planned Strategic Acquisition of Clear Com Media Inc.
WINDSOR, ON / ACCESSWIRE / April 20, 2021 / CEN Biotech Inc. ("CEN" or the "Company") (OTC Pink: CENBF), a global holding company focused on the manufacturing, production, and development of LED light...